CIM
BMY icon

Chiron Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Chiron Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4.77M Buy
+84,294
New +$4.71M 1.59% 27
2023
Q2 		– Sell
-4,824
Closed -$334K – 131
2023
Q1 		$334K Hold
4,824
– – 0.06% 92
2022
Q4 		$347K Hold
4,824
– – 0.08% 62
2022
Q3 		$343K Buy
+4,824
New +$350K 0.07% 67

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chiron Investment Management's BMY Position: Q4 2024 in Review

Chiron Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2024: 84,294 shares worth $4.77M. The stake represents 1.59% of the portfolio and ranks #27 among its holdings. This is a return to the name: Chiron Investment Management previously reported a position in BMY as recently as Q1 2023.

Chiron Investment Management first reported a position in BMY in Q3 2022 and has held it in 4 quarters since. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Chiron Investment Management held 84,294 shares of Bristol-Myers Squibb worth $4.77M as of Q4 2024.
  • Bristol-Myers Squibb was a new Chiron Investment Management position in Q4 2024.
  • Bristol-Myers Squibb made up 1.59% of Chiron Investment Management's portfolio in Q4 2024, its #27 holding.
  • Chiron Investment Management first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 4 quarters since.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.